ALEC
Price
$1.71
Change
+$0.03 (+1.79%)
Updated
Jan 17 closing price
Capitalization
167.46M
72 days until earnings call
BLTE
Price
$56.21
Change
+$3.17 (+5.98%)
Updated
Jan 17 closing price
Capitalization
1.74B
68 days until earnings call
Ad is loading...

ALEC vs BLTE

Header iconALEC vs BLTE Comparison
Open Charts ALEC vs BLTEBanner chart's image
Alector
Price$1.71
Change+$0.03 (+1.79%)
Volume$529.39K
Capitalization167.46M
Belite Bio
Price$56.21
Change+$3.17 (+5.98%)
Volume$42.76K
Capitalization1.74B
ALEC vs BLTE Comparison Chart
Loading...
ALEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BLTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALEC vs. BLTE commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALEC is a Hold and BLTE is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (ALEC: $1.71 vs. BLTE: $56.21)
Brand notoriety: ALEC and BLTE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALEC: 33% vs. BLTE: 72%
Market capitalization -- ALEC: $167.46M vs. BLTE: $1.74B
ALEC [@Biotechnology] is valued at $167.46M. BLTE’s [@Biotechnology] market capitalization is $1.74B. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALEC’s FA Score shows that 0 FA rating(s) are green whileBLTE’s FA Score has 0 green FA rating(s).

  • ALEC’s FA Score: 0 green, 5 red.
  • BLTE’s FA Score: 0 green, 5 red.
According to our system of comparison, both ALEC and BLTE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALEC’s TA Score shows that 2 TA indicator(s) are bullish while BLTE’s TA Score has 4 bullish TA indicator(s).

  • ALEC’s TA Score: 2 bullish, 5 bearish.
  • BLTE’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, BLTE is a better buy in the short-term than ALEC.

Price Growth

ALEC (@Biotechnology) experienced а -5.00% price change this week, while BLTE (@Biotechnology) price change was +1.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

ALEC is expected to report earnings on May 01, 2025.

BLTE is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BLTE($1.74B) has a higher market cap than ALEC($167M). ALEC YTD gains are higher at: -9.524 vs. BLTE (-10.919). BLTE has higher annual earnings (EBITDA): -35.42M vs. ALEC (-176.18M). ALEC has higher revenues than BLTE: ALEC (61.5M) vs BLTE (0).
ALECBLTEALEC / BLTE
Capitalization167M1.74B10%
EBITDA-176.18M-35.42M497%
Gain YTD-9.524-10.91987%
P/E RatioN/AN/A-
Revenue61.5M0-
Total Cash457MN/A-
Total Debt34.6MN/A-
FUNDAMENTALS RATINGS
ALEC: Fundamental Ratings
ALEC
OUTLOOK RATING
1..100
77
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
94
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALECBLTE
RSI
ODDS (%)
Bullish Trend 11 days ago
83%
Bullish Trend 11 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 11 days ago
90%
Bullish Trend 11 days ago
77%
Momentum
ODDS (%)
Bearish Trend 11 days ago
88%
Bearish Trend 11 days ago
73%
MACD
ODDS (%)
N/A
Bearish Trend 11 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 11 days ago
86%
Bearish Trend 11 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
86%
Bearish Trend 11 days ago
76%
Advances
ODDS (%)
Bullish Trend 27 days ago
81%
Bullish Trend 17 days ago
75%
Declines
ODDS (%)
Bearish Trend 11 days ago
85%
Bearish Trend 13 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 11 days ago
83%
Bullish Trend 11 days ago
87%
Aroon
ODDS (%)
Bearish Trend 11 days ago
85%
Bearish Trend 11 days ago
69%
View a ticker or compare two or three
Ad is loading...
ALEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BLTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GEQZX59.680.59
+1.00%
GuideStone Funds Equity Index Investor
SVPSX87.190.43
+0.50%
ProFunds Small Cap Value Svc
WFTIX13.150.06
+0.46%
Allspring Innovation Fund - Class Inst
SFSLX26.120.07
+0.27%
1919 Financial Services C
FSCOX19.520.05
+0.26%
Fidelity International Small Cap Opp

BLTE and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLTE has been loosely correlated with RAIN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if BLTE jumps, then RAIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLTE
1D Price
Change %
BLTE100%
+5.98%
RAIN - BLTE
48%
Loosely correlated
+7.73%
ELVN - BLTE
27%
Poorly correlated
-2.36%
ACOG - BLTE
24%
Poorly correlated
+0.17%
ALEC - BLTE
24%
Poorly correlated
+1.79%
TVTX - BLTE
23%
Poorly correlated
-0.54%
More